Showing 1 - 7 results of 7 for search 'Benjamin Lidgard', query time: 0.03s Refine Results
  1. 1
    Apixaban Dosing in Patients With Kidney Failure Treated With Peritoneal Dialysis

    Apixaban Dosing in Patients With Kidney Failure Treated With Peritoneal Dialysis by Benjamin Lidgard, Jenny I. Shen

    Published 2023-08-01
    Get full text
    Article
  2. 2
    Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High‐Sensitivity Troponin T, and N‐Terminal Pro–Brain‐Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction

    Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High‐Sensitivity Troponin T, and N‐Terminal Pro–Brain‐Type Natriuretic Peptide for... by Benjamin Lidgard, Leila R. Zelnick, Alan Go, Kevin D. O’Brien, Nisha Bansal

    Published 2022-06-01
    Get full text
    Article
  3. 3
    High-Density Lipoprotein Lipidomics and Mortality in CKD

    High-Density Lipoprotein Lipidomics and Mortality in CKD by Benjamin Lidgard, Andrew N. Hoofnagle, Leila R. Zelnick, Ian H. de Boer, Amanda M. Fretts, Bryan R. Kestenbaum, Rozenn N. Lemaitre, Cassianne Robinson-Cohen, Nisha Bansal

    Published 2023-10-01
    Get full text
    Article
  4. 4
    Evaluation of plasma sphingolipids as mediators of the relationship between kidney disease and cardiovascular eventsResearch in context

    Evaluation of plasma sphingolipids as mediators of the relationship between kidney disease and cardiovascular eventsResearch in context by Benjamin Lidgard, Nisha Bansal, Leila R. Zelnick, Andrew N. Hoofnagle, Amanda M. Fretts, William T. Longstreth, Jr., Michael G. Shlipak, David S. Siscovick, Jason G. Umans, Rozenn N. Lemaitre

    Published 2023-09-01
    Get full text
    Article
  5. 5
    Circulating Sphingolipids and All‐Cause Mortality: The Strong Heart Family Study

    Circulating Sphingolipids and All‐Cause Mortality: The Strong Heart Family Study by Amanda M. Fretts, Paul N. Jensen, Colleen M. Sitlani, Andy Hoofnagle, Benjamin Lidgard, Jason G. Umans, David S. Siscovick, Irena B. King, Barbara V. Howard, Shelley A. Cole, Rozenn N. Lemaitre

    Published 2024-07-01
    Get full text
    Article
  6. 6
    Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease

    Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease by Armin Ahmadi, Gwenaelle Begue, Ana P. Valencia, Jennifer E. Norman, Benjamin Lidgard, Brian J. Bennett, Matthew P. Van Doren, David J. Marcinek, Sili Fan, David K. Prince, Jorge Gamboa, Jonathan Himmelfarb, Ian H. de Boer, Bryan R. Kestenbaum, Baback Roshanravan

    Published 2023-06-01
    Get full text
    Article
  7. 7
    Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study

    Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study by Simon Hsu, Leila R. Zelnick, Nisha Bansal, Julia Brown, Michelle Denburg, Harold I. Feldman, Charles Ginsberg, Andrew N. Hoofnagle, Tamara Isakova, Mary B. Leonard, Benjamin Lidgard, Cassianne Robinson‐Cohen, Myles Wolf, Dawei Xie, Bryan R. Kestenbaum, Ian H. de Boer

    Published 2023-07-01
    Get full text
    Article

Search Tools: